FNDC5 and breast carcinoma: They participate in several physiological and pathological processes, for example, lipid metabolism and cancer progression.[11–13] Currently, irisin was found to improve the quality of skeleton[14] and its serum concentration in patients with breast cancer was lower than healthy participants.[15] In addition, there still remains a debate about its role in metabolic syndrome (MetS).